Saturday 17 October 2026
Export POCI’s income statement to Excel — free account
Precision Optics Corp.
POCI Healthcare Medical Instruments & Supplies
Precision Optics Corp.’s revenue for fiscal 2026 (year ended June 2026) was $31.5 million, up 65.2% from fiscal 2025. In the quarter to June 2026, revenue grew 42.0%, EPS grew 117.4%, free cash flow fell 45.6% and total debt fell 31.0%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
4.26
0.09
−2.07%
Follow POCI
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
1.56 | 1.32 | 1.18 | 1.38 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
429.16 | (126.22) | (47.31) | (67.03) | |
P/B ratio |
3.07 | 3.46 | 1.70 | 2.14 | |
Price to Tangible BV |
17.92 | 113.23 | 3.09 | 3.85 | |
EV/Sales |
1.57 | 1.35 | 0.86 | 1.11 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(11.30) | (13.38) | (18.94) | (22.55) | |
EV/FCF |
(9.67) | (10.86) | (14.26) | (17.66) | |
Quick Ratio |
0.73 | 0.58 | 1.69 | 1.79 | |
Current Ratio |
1.29 | 1.05 | 2.10 | 2.28 | |
Net Debt/EBITDA |
(0.22) | (0.42) | (833.01) | 202.65 | |
Debt/Assets |
7.70% | 6.89% | 4.26% | 3.99% | |
Debt/Equity |
0.16 | 0.17 | 0.07 | 0.06 | |
Asset Turnover |
1.09 | 1.21 | 1.09 | 1.21 | |
Operating CF/Net income |
(0.05) | 0.14 | 6.68 | 6.25 | |
Capex/Depreciation |
(4.63) | (1.30) | 0.65 | (1.25) | |
Interest Coverage |
(38.17) | (45.25) | (1.84) | (3.25) | |
Research and Development Expense of Revenue |
4.67% | 3.39% | 3.07% | 2.33% | |
Selling, General and Administrative Expense of Revenue |
33.38% | 23.04% | 21.29% | 24.23% | |
Intangible Assets out of Total Assets |
0.40 | 0.40 | 0.27 | 0.28 | |
Share Based Compensation of Revenue |
4.51% | 2.54% | 2.91% | 4.53% | |
Graham Net Nets |
(0.05) | (0.10) | 0.23 | 0.19 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(19.31%) | (21.96%) | (14.44%) | (8.28%) | |
Free Cash Flow Yield |
(10.45%) | (9.40%) | (5.12%) | (4.55%) | |
Revenue per Share |
0.87 | 0.96 | 1.12 | 1.03 | |
Operating CF per Share |
0.01 | (0.03) | (0.09) | (0.08) | |
Capex per Share |
(0.04) | (0.01) | 0.01 | (0.01) | |
Free Cash Flow per Share |
(0.03) | (0.05) | (0.09) | (0.09) | |
Cash per Share |
0.18 | 0.11 | 1.37 | 1.15 | |
Shareholders Equity per Share |
1.42 | 1.21 | 2.58 | 2.39 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.42 | 1.21 | 2.58 | 2.39 | |
Free Cash Flow |
(0.22) | (0.35) | (0.67) | (0.73) | |
Working Capital |
2.24 | 0.47 | 11.21 | 11.28 | |
Capital Expenditures |
(0.30) | (0.10) | 0.05 | (0.08) | |
Net Current Asset Value |
(1.60) | (3.14) | 7.83 | 8.12 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.05 | 0.01 | (0.01) | 0.01 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
3.66 | 4.19 | 5.00 | 5.14 | |
Average Payables |
3.08 | 4.39 | 4.06 | 3.25 | |
Average Inventory |
3.67 | 4.06 | 3.69 | 3.70 | |
Average Assets |
19.81 | 20.20 | 26.65 | 26.06 | |
Average Common Equity |
10.53 | 9.40 | 16.64 | 16.30 |
Columns are period end dates · fundamentals updated 30 Sep 2026